Entresto Release Delayed As Novartis Goes To Fed. Circ.

By Dani Kass · August 13, 2024, 9:20 PM EDT

A Delaware federal judge said Monday that Novartis is unlikely to prove that it's entitled to an injunction that would block MSN Pharmaceuticals from launching a generic version of its top-selling...

To view the full article, register now.

Documents

Case Information

Case Title

In re: Entresto (Sacubitril/Valsartan) Patent Litigation

Case Number

1:20-md-02930

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

March 27, 2020


Case Title

Novartis Pharmaceuticals Corporation v. Hetero USA, Inc.

Case Number

24-2209

Court

Appellate - Federal Circuit

Nature of Suit

835 Patent - (ANDA) (Fed. Qst.)

Date Filed

August 13, 2024